These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 17280478)
41. Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis. Shimizu H; Seki K; Shiga K; Nakayama T; Mori M Vaccine; 2018 Sep; 36(40):5935-5939. PubMed ID: 30153996 [TBL] [Abstract][Full Text] [Related]
42. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Slack MH; Schapira D; Thwaites RJ; Schapira C; Bamber J; Burrage M; Southern J; Andrews N; Miller E Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F57-60. PubMed ID: 14711858 [TBL] [Abstract][Full Text] [Related]
43. Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. Xu Y; Wang Y; Tan Y; Zhang H; Wu L; Wang L; Hou Q; Zhang S BMC Microbiol; 2009 Dec; 9():274. PubMed ID: 20040101 [TBL] [Abstract][Full Text] [Related]
44. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related]
45. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice]. Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410 [TBL] [Abstract][Full Text] [Related]
47. Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults. Gröndahl-Yli-Hannuksela K; Kauko L; Van Der Meeren O; Mertsola J; He Q Vaccine; 2016 Jan; 34(3):341-9. PubMed ID: 26643932 [TBL] [Abstract][Full Text] [Related]
51. Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China. Wu S; Hu Q; Yang C; Zhou H; Chen H; Zhang Y; Jiang M; He Y; Shi X Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):53. PubMed ID: 34407803 [TBL] [Abstract][Full Text] [Related]
52. Quantitative determination of bioactive proteins in diphtheria tetanus acellular pertussis (DTaP) vaccine by liquid chromatography tandem mass spectrometry. Long Z; Wei C; Zhan Z; Ma X; Li X; Li Y; Yao J; Ji F; Li C; Huang T J Pharm Biomed Anal; 2019 May; 169():30-40. PubMed ID: 30831450 [TBL] [Abstract][Full Text] [Related]
53. Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model. Kang KR; Kim JA; Cho GW; Kang HU; Kang HM; Kang JH; Seong BL; Lee SY Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38276680 [TBL] [Abstract][Full Text] [Related]
54. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Guiso N; Njamkepo E; Vié le Sage F; Zepp F; Meyer CU; Abitbol V; Clyti N; Chevallier S Vaccine; 2007 Feb; 25(8):1390-7. PubMed ID: 17134795 [TBL] [Abstract][Full Text] [Related]